ELAN (STOCKS)
Elanco Animal Health Incorporated Common Stock
$24.290000
+0.120000 (+0.50%)
Prev close: $24.170000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeffrey N. Simmons
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12,131.64M
- Employees
- 9,450
- P/E (TTM)
- -49.66
- P/B (TTM)
- 1.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $4.89B |
| Benefits Costs and Expenses | $5.09B |
| Cost Of Revenue | $2.20B |
| Costs And Expenses | $5.09B |
| Gross Profit | $2.69B |
| Operating Expenses | $2.89B |
| Selling, General, and Administrative Expenses | $1.47B |
| Research and Development | $371.00M |
| Other Operating Expenses | $1.05B |
| Operating Income/Loss | -$197.00M |
| Income/Loss From Continuing Operations After Tax | -$242.00M |
| Income/Loss From Continuing Operations Before Tax | -$197.00M |
| Income Tax Expense/Benefit | $45.00M |
| Net Income/Loss | -$242.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$242.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$242.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.50 |
| Diluted Earnings Per Share | -$0.50 |
| Basic Average Shares | 1,491,300,000 |
| Diluted Average Shares | 1,498,100,000 |
| Assets | $13.22B |
| Current Assets | $3.58B |
| Inventory | $1.72B |
| Other Current Assets | $1.87B |
| Noncurrent Assets | $9.64B |
| Fixed Assets | $1.40B |
| Intangible Assets | $3.23B |
| Other Non-current Assets | $5.02B |
| Liabilities | $6.72B |
| Current Liabilities | $1.66B |
| Accounts Payable | $372.00M |
| Other Current Liabilities | $1.29B |
| Noncurrent Liabilities | $5.06B |
| Long-term Debt | $3.74B |
| Other Non-current Liabilities | $1.32B |
| Equity | $6.50B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.50B |
| Liabilities And Equity | $13.22B |
| Net Cash Flow From Operating Activities | $577.00M |
| Net Cash Flow From Operating Activities, Continuing | $577.00M |
| Net Cash Flow From Investing Activities | -$281.00M |
| Net Cash Flow From Investing Activities, Continuing | -$281.00M |
| Net Cash Flow From Financing Activities | -$392.00M |
| Net Cash Flow From Financing Activities, Continuing | -$392.00M |
| Exchange Gains/Losses | $37.00M |
| Net Cash Flow | -$59.00M |
| Net Cash Flow, Continuing | -$96.00M |
| Comprehensive Income/Loss | -$283.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $108.00M |
| Other Comprehensive Income/Loss | -$294.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $350.00M |